Aster DM Healthcare Limited

97%

ss geographies 2015: First clinic in Bahrain and in the Philippines 2016: Increased stake up to 97% in Sanad Medical Care (KSA) 2016: Medcare Women and Children Hospital (UAE) 2017: Medcare Hospi

INR 6,532

) India : 2263 (214) India : 251 (159) Largest Number of Medical Centers/Polyclinics in the GCC INR 6,532 Cr (5,478 Cr) Revenue6 GCC : INR 4,760 Cr (4,070 Cr) India : INR 1,772 Cr (1,408 Cr) 918 (769)

INR 4,760

Largest Number of Medical Centers/Polyclinics in the GCC INR 6,532 Cr (5,478 Cr) Revenue6 GCC : INR 4,760 Cr (4,070 Cr) India : INR 1,772 Cr (1,408 Cr) 918 (769) Total Facilities Net Unit Additions in

INR 1,772

s/Polyclinics in the GCC INR 6,532 Cr (5,478 Cr) Revenue6 GCC : INR 4,760 Cr (4,070 Cr) India : INR 1,772 Cr (1,408 Cr) 918 (769) Total Facilities Net Unit Additions in FY24 Q2 Total : 1 Hospital | 4 Cli

rs7

1 PEC’s One of the Largest Chain of Pharmacies in the UAE 33,904* (28,428) Human Resources Doctors7 : 4,201 Nurses : 9,763 Others8 : 14,200 Outsourced8 : 5,740 Notes: 1. Count includes 4 O&M Asset

rs8

n of Pharmacies in the UAE 33,904* (28,428) Human Resources Doctors7 : 4,201 Nurses : 9,763 Others8 : 14,200 Outsourced8 : 5,740 Notes: 1. Count includes 4 O&M Asset Light Hospitals with a capacity

rs 191

s 276 Pharmacies H – Hospitals C – Clinics P – Pharmacies L – Labs PEC – Patient Experience Centers 191 Hospitals 13 Clinics 2262 Pharmacies 2513 Labs 1. Count includes 4 O&M Asset Light Hospitals wit

27%

ters Aster DM Healthcare – Financial Overview 8 Revenue - FY24 H1 EBITDA - FY24 H1 India India 27% (PY: XX%) (PY : 26%) GCC GCC 73% (PY: XX%) (PY : 74%) Revenue - FY24 H1 Pharmacies Pharmacies 2

26%

hcare – Financial Overview 8 Revenue - FY24 H1 EBITDA - FY24 H1 India India 27% (PY: XX%) (PY : 26%) GCC GCC 73% (PY: XX%) (PY : 74%) Revenue - FY24 H1 Pharmacies Pharmacies 25% (PY: XX%) (PY : 2

73%

ial Overview 8 Revenue - FY24 H1 EBITDA - FY24 H1 India India 27% (PY: XX%) (PY : 26%) GCC GCC 73% (PY: XX%) (PY : 74%) Revenue - FY24 H1 Pharmacies Pharmacies 25% (PY: XX%) (PY : 25%) (PY : 24%)

74%

enue - FY24 H1 EBITDA - FY24 H1 India India 27% (PY: XX%) (PY : 26%) GCC GCC 73% (PY: XX%) (PY : 74%) Revenue - FY24 H1 Pharmacies Pharmacies 25% (PY: XX%) (PY : 25%) (PY : 24%) Clinics Clinics 18

25%

% (PY: XX%) (PY : 26%) GCC GCC 73% (PY: XX%) (PY : 74%) Revenue - FY24 H1 Pharmacies Pharmacies 25% (PY: XX%) (PY : 25%) (PY : 24%) Clinics Clinics 18% (PY : 19%) (PY : 20%) (PY: XX%) Hospitals Ho

“Aster Labs was established in 2019, WE WILL TREAT YOU WELL is the brand promise that every analysis will be most accurate, and help doctors to diagnose better and ultimately help patients recover faster.”

“Target is to also offer Molecular Diagnostics and High end & advanced tests in future.”

“We expect this to yield significant gains to business in the coming years India Strategy Aster DM Healthcare hopes to leverage its extensive experience of working in a 100% insurance market in the GCC to derive better margins due to the increasing share of Insurance segment in the Indian market The current central government has focused significantly on continuous reformation that impacts the health sector.”

Notes

9

Note

3

Source

1

Notes

1. Count includes 4 O&M Asset Light Hospitals with a capacity of 528 beds 2. GCC Retail Pharmacies includes Opticals 3. Pharmacies in India operated by ARPPL under brand license from Aster 4. As on 30th September 2023, India has 1 reference lab, 15 satellite labs, 235 Patient Experience Centers (PEC) 5. 6. Revenue shown above excludes other income; Financial numbers are rounded to the nearest integer 7. Full-time doctors India patient visit count excludes pharmacy and lab visits 8. Other employee count in India includes the count of 635 which is for shared service support to GCC. Outsourced employee count in India includes the count of 15 which is for shared service support to GCC 9. Numbers in brackets () are for FY23 H1 *GCC: Doctors: 1,651 Nurses: 3,679 Others: 6,178 Outsourced : 1,408 India: Doctors: 2,550 Nurses: 6,084 Others: 8,022 Outsourced : 4,332 Geographical Footprint 7 7 United Arab Emirates H(9) C(104) P(253) Kingdom of Saudi Arabia H(1) Andhra Pradesh H(7) C(2) P(86) L(6)

Note

1. Revenue and EBITDA shown above excludes other income Above shown percentage of revenue and EBITDA by hospitals, clinics and pharmacies are calculated based on gross segmental numbers before allocation of inter-segment revenue and unallocated corporate overheads All the numbers above are post IndAS 116 Percentages in bracket represent revenue and EBITDA for PY – Previous Year India Clinics which was previously classified under Hospitals, is now included under Clinics 5. 4. 3. 6. Wholesale Pharmacy which was previously classified under Hospitals, is now included under Pharmacies India Labs are being classified under Hospitals 7. 8. Numbers in brackets are for H1 FY23 GCC Hospitals UAE Aster Hospital Mankhool Dubai CB:140 OB:118 2015, Leased Aster Hospital Qusais Dubai CB:163 OB:126 2018, Leased Cedars Hospital Dubai CB:20 OB:12 2019, Leased Aster Hospital Sonapur Dubai CB:35 OB:25 2020, Leased Medcare Hospital Dubai CB:64 OB:55 2007, Leased Medcare Orthopaedics and Spine Hospital Duba

Note

1. Out-Patient visits mentioned above does not include pharmacy visits FY22 Outpatient count includes 3.3 mn relating to Covid testing 2. Capacity beds shown above excludes O&M beds of WIMS hospital which was included in bed count in the previous presentations 3. FY21 numbers have an impact of COVID 4. Pharmacies in India operated by ARPPL under brand license from Aster 5. As on 30th September 2023, India has 1 reference lab, 15 satellite labs, 235 patient experience centers (PEC) 6. 7. Hospital count includes 4 O&M Asset Light Hospitals with a capacity of 528 beds FY23 32 127 264 257 205 885 FY23 H1 FY24 H1 30 121 245 214 159 769 34 131 276 226 251 918 14 AN INTEGRATED HEALTHCARE PROVIDER Aster – An Integrated Healthcare Provider Aster - An Integrated Healthcare Provider FY23 Operational Information 15 ~5.1 mn Clinic OPD Visits ~ 9.8 mn Pharmacy Visits ~ 4.7 mn Hospital OPD visits 326,300+ IP Discharges 22,800+ General Surgeries 4,000+ Joint Replacements 17,700+ Urology Cases 25,200+

Note

*Transplants includes kidney, heart, liver, pancreas, etc. Aster – A Healthcare Ecosystem 16 Patient Life Cycle Management Hospitals Clinics Pharmacies GCC INDIA • Indian operations act as a source of talent (Doctors, Nurses, and other employees) to GCC operations • Within GCC operations, Clinic Doctors have the opportunity to hone their surgical skills in Aster’s Hospitals • Aster, over 35 years, has created a Healthcare Ecosystem across two geographical regions • In GCC region, Aster’s Primary Care Clinics act as the initial touchpoints in the patients' journey, while Pharmacies and Hospitals continue the care • For complex Tertiary Care, patients are transferred to Aster’s Hospitals in India Hospitals Clinics Resource Talent Management Digital Health Currently ranks #1 among the Free Apps in Medical Category in the UAE 17 Virtual Care – Omni-channel experience Online Pharmacy § Influx of 1.3M unique users (29% growth over Q1 ) § Over 220K+ net Installs of the App in the UAE in Q2FY2

Source

1. english.alarabiya.net 2. worldpopulationreview.com 3. 4. omanobserver.com edsfze.com operating leverage Ø Seasonality variation consistently visible over several years, can be expected to continue Aster - Awards & Service Excellence Dr. Azad Moopen Chairman & Managing Director • Recipient of the “Padma Shri” Award, the 4th highest civilian award by the Government of India for being recognized across countries for his contributions in 2011 • Honored with the ‘Pravasi Bharatiya Samman’ by the Government of India in 2010 • Awarded by Harvard Business Council for Organizational Excellence in 2021 • Honored with the prestigious ‘Lifetime Achievement Award’ at 10th FICCI Healthcare Excellence Awards in 2018 • Honored with a Doctorate for Philanthropy by Amity University in 2022 Alisha Moopen Deputy Managing Director 21 21 • Elected by World Economic Forum as a Young Global Leader • Harvard Business Council International Executives’ Award 2020 (Diamond Level) • Featured in Arabian Business

Notes

1. Above financials are presented in INR Crore and post IndAS 116 2. Percentages mentioned inside the bars are % to revenue excluding other income 3. Constant currency growth of Revenue and EBITDA is 15% and 17% respectively 4. Aster Royal Hospital Muscat, Aster Narayanadri Tirupati, Aster G Madegowda Mandya ,Ramesh (IB) Vijayawada, Aster Whitefield Block A&B Bengaluru and Aster PMF Kollam are classified as new hospitals. 5. Reported PAT and Adjusted PAT are Post Non-Controlling Interest. 6. Operating EBITDA for the period Q2 F24 excludes the ESOP cost of Rs. 2.1 Cr, variable O&M fee amounting to Rs.6.8 Cr [Q2 FY23 : 4.8 Cr] and restructuring cost of Rs. 6.5 Cr.[Our Operating & Management (O&M) agreements, encompasses both fixed and variable component. While the fixed component of the O&M fee is delineated into depreciation and finance costs as per Ind AS 116, whereas the variable component falls outside the scope of Ind AS 116, leading to an incomplete reflection of the standard's imp